Snap’s Evan Spiegel on AI, AR, and – yes – TikTok
The Snap CEO talks about the challenges facing the company’s AI chatbot, how augmented reality glasses could change how we compute the real world and why a TikTok ban would “help” Snap. You can foll...
1 Mai 202357min
Ron Klain on the Likely Biden-Trump 2024 Showdown
It’s looking like 2024 will be another round of Biden vs. Trump. But will the sequel end in the same result? Here to discuss the prospective race — and the many issues at stake from abortion to gun co...
27 Apr 202351min
Ben Smith on the Turmoil at Buzzfeed, Fox News and Everything In Between
To make sense of a turbulent and important week in media, we turn to Ben Smith who was the founding Editor in Chief of Buzzfeed News (2012 to 2020) and the former New York Times media critic (from 202...
24 Apr 20231h 4min
Larry Summers on the Politics & Economics of Envy
We turn to economist and former Treasury Secretary, Lawrence Summers, to help us make sense of inflation, Silicon Valley Bank and what Biden should do next. Also on the agenda: why Summers believes in...
20 Apr 202355min
Jen Psaki on Her New Show and Her Old Boss
After a quick rundown of how the 2024 presidential race may shape up, we turn to today’s guest: Jen Psaki, the former White House Press Secretary and host of the new MSNBC show, “Inside with Jen Psaki...
17 Apr 202353min
Inside the Elon-Substack Drama with Chris Best & Hamish McKenzie
Last week, Elon kicked off a feud with both Substack and his very own former Twitter Files ingénue (and Substack star), Matt Taibbi. Kara and Nayeema break down the battle of the bros before turning t...
13 Apr 202354min
What Rupert Murdoch and Succession’s Logan Roy Have in Common (and Don’t)
Today, after Kara and Nayeema discuss what the Dominion defamation lawsuit might mean for Rupert Murdoch and News Corp, we turn to a fictional media story of Logan Roy and HBO’s Succession. Our guests...
10 Apr 20231h 8min
WeightWatchers CEO Sima Sistani talks TikTok, Telehealth Deal on GLP-1/Ozempic and Why She Took the Job
WeightWatchers recently announced a $132 million deal to acquire telehealth company Sequence and enter the prescription drug space (think: GLP-1 drugs like Wegovy and Ozempic). It begs the question: w...
6 Apr 202354min
